SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015517
Filing Date
2022-08-08
Accepted
2022-08-08 16:08:00
Documents
56
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrus-20220630.htm   iXBRL 10-Q 3113037
2 EX-31.1 mrus-ex31_1.htm EX-31.1 20783
3 EX-32.1 mrus-ex32_1.htm EX-32.1 12800
  Complete submission text file 0000950170-22-015517.txt   9802866

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrus-20220630_cal.xml EX-101.CAL 47933
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrus-20220630_lab.xml EX-101.LAB 338552
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrus-20220630_def.xml EX-101.DEF 155677
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrus-20220630.xsd EX-101.SCH 41168
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrus-20220630_pre.xml EX-101.PRE 246645
50 EXTRACTED XBRL INSTANCE DOCUMENT mrus-20220630_htm.xml XML 2123031
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37773 | Film No.: 221144401
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences